Thermo Fisher’s (NYSE:TMO) Q4 Sales Beat Estimates - Yahoo …

Jan 30, 2025 · Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 4.7% year on year to $11.4 billion. …

CouponFollow Extension

7%
OFF

Thermo Fisher’s (NYSE:TMO) Q4 Sales Beat Estimates - Yahoo …

2 weeks from now

Jan 30, 2025 · Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 4.7% year on year to $11.4 billion. …

yahoo.com

9%
OFF

Thermo Fisher Q4 Earnings And Revenues Top Estimates, Stock Up

2 weeks from now

Thermo Fisher Scientific Inc.'s TMO fourth-quarter 2024 adjusted earnings per share (EPS) of $6.10 beat the Zacks Consensus Estimate by 2.9%. The figure increased 7.6% year over year. …

yahoo.com

6%
OFF

Thermo Fisher Stock Surges 6.6% As Q4 Earnings Smash Estimates …

2 weeks from now

Jan 30, 2025 · Thermo Fisher Scientific (NYSE:TMO) just crushed expectations, sending its stock up 6.6% this morning as investors cheered a strong Q4 and an even stronger outlook for 2025. …

yahoo.com

7%
OFF

Thermo Fisher (TMO) Q4 Earnings: Taking A Look At Key Metrics …

2 weeks from now

Jan 30, 2025 · Thermo Fisher Scientific (TMO) reported $11.4 billion in revenue for the quarter ended December 2024, representing a year-over-year increase of 4.7%. EPS of $6.10 for the …

yahoo.com

7%
OFF

Thermo Fisher’s (NYSE:TMO) Q4 Sales Beat Estimates

2 weeks from now

Jan 30, 2025 · In Q4, Thermo Fisher reported EPS at $6.10, up from $5.67 in the same quarter last year. This print beat analysts’ estimates by 2.7%. Over the next 12 months, Wall Street …

financialcontent.com

$6.10
OFF

Thermo Fisher Scientific (TMO) Q4 Earnings And Revenues Top …

2 weeks from now

Jan 30, 2025 · Thermo Fisher Scientific (TMO) came out with quarterly earnings of $6.10 per share, beating the Zacks Consensus Estimate of $5.93 per share. This compares to earnings …

yahoo.com

5%
OFF

Thermo Fisher Scientific Inc (TMO) Q4 2024 Earnings Call …

2 weeks from now

Jan 31, 2025 · Thermo Fisher Scientific Inc reported strong revenue growth of 5% year over year in Q4, reaching $11.4 billion. The company achieved an 8% increase in adjusted EPS for Q4, …

yahoo.com

30%
OFF

Thermo Fisher Scientific (TMO) Q4 2024 Earnings Call Transcript

2 weeks from now

Jan 30, 2025 · NYSE: TMO Thermo Fisher Scientific. Market Cap. $222B. ... Thermo Fisher Scientific (TMO 0.30%) Q4 2024 Earnings Call Jan 30, ... We beat Q4 organic growth by just …

fool.com

5%
OFF

Thermo Fisher Q4 Earnings Beat Estimates, Margin Expands

2 weeks from now

Jan 30, 2025 · Zinger Key Points. Thermo Fisher Q4 earnings of $6.10 per share beat estimates, with 5% YoY sales growth to $11.395B. Full-year revenue growth was flat, and long-term …

benzinga.com

5%
OFF

Thermo Fisher Q4 Earnings Beat Estimates, Margin Expands

2 weeks from now

Jan 30, 2025 · Thermo Fisher Q4 earnings of $6.10 per share beat estimates, with 5% YoY sales growth to $11.395B. Full-year revenue growth was flat, and long-term obligations rose to …

benzinga.com

3%
OFF

Thermo Fisher (TMO) Q4 Earnings Beat Estimates, Margins Down

2 weeks from now

Thermo Fisher Scientific Inc.'s TMO fourth-quarter 2021 adjusted earnings per share (EPS) of $6.54 beat the Zacks Consensus Estimate by 25.3%. However, the figure declined 7.8% year …

yahoo.com

7%
OFF

Thermo Fisher’s (NYSE:TMO) Q4 Sales Beat Estimates

2 weeks from now

Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 4.7% year on year to $11.4 billion. Its non-GAAP …

theglobeandmail.com

$5.94
OFF

Thermo Fisher Scientific Inc. (NYSE:TMO) Earnings ...

2 weeks from now

Jan 29, 2025 · Thermo Fisher Scientific Inc. is expected to report an earnings per share (EPS) of $5.94 and projected revenue of approximately $11.28 billion for the quarter ending December …

financialmodelingprep.com

7%
OFF

Thermo Fisher’s (NYSE:TMO) Q4 Sales Beat Estimates

2 weeks from now

Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2024 results , with sales up 4.7% year on year to $11.4 billion. Its non-GAAP profit of $6.10 per share was 2.7% above …

msn.com

7%
OFF

Thermo Fisher’s (NYSE:TMO) Q4 Sales Beat Estimates

2 weeks from now

Jan 30, 2025 · Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 4.7% year on year to $11.4 billion.Its …

financialcontent.com

FAQs about Thermo Fisher’s (NYSE:TMO) Q4 Sales Beat Estimates - Yahoo … Coupon?

How did Thermo Fisher Scientific (TMO) perform in Q4 2024?

Thermo Fisher Scientific Inc. 's TMO fourth-quarter 2024 adjusted earnings per share (EPS) of $6.10 beat the Zacks Consensus Estimate by 2.9%. The figure increased 7.6% year over year. Find the latest EPS estimates and surprises on Zacks Earnings Calendar. ...

Is Thermo Fisher Scientific (TMO) a good stock to buy?

Thermo Fisher Scientific (NYSE:TMO) just crushed expectations, sending its stock up 6.6% this morning as investors cheered a strong Q4 and an even stronger outlook for 2025. Revenue jumped 5% to $11.40 billion, while adjusted EPS climbed 8% to $6.10, beating Wall Street estimates. ...

How did Thermo Fisher perform in Q4?

In Q4, Thermo Fisher reported EPS at $6.10, up from $5.67 in the same quarter last year. This print beat analysts’ estimates by 2.7%. Over the next 12 months, Wall Street expects Thermo Fisher’s full-year EPS of $21.86 to grow 5.2%. It was good to see Thermo Fisher narrowly beat analysts’ organic revenue expectations this quarter. ...

How much equity does Thermo Fisher Scientific Inc have?

(645 Equity in earnings/losses of unconsolidated entities 42 59 Noncontrolling interests adjustments (f) (19 (46 Adjusted net income (non-GAAP measure) 8,380 8,364 Reconciliation of adjusted earnings per share GAAP diluted EPS attributable to Thermo Fisher Scientific Inc. ...

How did Thermo Fisher's organic revenue perform over the last two years?

Over the last two years, Thermo Fisher’s organic revenue averaged 2.8% year-on-year declines. Because this number aligns with its normal revenue growth, we can see the company’s core operations (not acquisitions and divestitures) drove most of its results. ...

Is Thermo Fisher's earnings estimate revisions trend unfavorable?

Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Thermo Fisher: unfavorable. ...